Clinical and economic impact of common multidrug-resistant gram-negative bacilli

Antimicrob Agents Chemother. 2008 Mar;52(3):813-21. doi: 10.1128/AAC.01169-07. Epub 2007 Dec 10.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acinetobacter / drug effects
  • Anti-Bacterial Agents / pharmacology*
  • Case-Control Studies
  • Cohort Studies
  • Drug Resistance, Multiple, Bacterial*
  • Escherichia coli / drug effects
  • Gram-Negative Bacteria / classification
  • Gram-Negative Bacteria / drug effects*
  • Gram-Negative Bacterial Infections* / drug therapy
  • Gram-Negative Bacterial Infections* / economics
  • Gram-Negative Bacterial Infections* / microbiology
  • Gram-Negative Bacterial Infections* / mortality
  • Hospital Costs
  • Humans
  • Klebsiella pneumoniae / drug effects
  • Length of Stay*
  • Pseudomonas aeruginosa / drug effects

Substances

  • Anti-Bacterial Agents